Angiogenin levels are increased in lesional skin and sera in patients with erythrodermic cutaneous T cell lymphoma
Archives of Dermatological Research, 05/21/2012
Miyagaki T et al. – As angiogenin acts as an inhibitor of polymorphonuclear leukocyte degranulation, angiogenin may also be linked to impaired host defense in erythrodermic cutaneous T cell lymphoma (CTCL),.



